BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21908018)

  • 1. Circulating microparticles and risk of venous thromboembolism.
    Bucciarelli P; Martinelli I; Artoni A; Passamonti SM; Previtali E; Merati G; Tripodi A; Mannucci PM
    Thromb Res; 2012 May; 129(5):591-7. PubMed ID: 21908018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating procoagulant microparticles in cancer patients.
    Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
    Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
    Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
    Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
    Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
    Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between red cell distribution width and risk of venous thromboembolism.
    Bucciarelli P; Maino A; Felicetta I; Abbattista M; Passamonti SM; Artoni A; Martinelli I
    Thromb Res; 2015 Sep; 136(3):590-4. PubMed ID: 26220270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
    Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
    Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of tissue factor bearing microparticles as biomarkers in allogeneic stem-cell transplantation.
    De Rop C; Stadler M; Buchholz S; Eisert R; Ganser A; Trummer A
    Transplantation; 2011 Aug; 92(3):351-8. PubMed ID: 21681142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
    Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
    Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
    Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
    Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
    Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels.
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Seifried E; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):524-34. PubMed ID: 19620844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low vegetable intake is strongly associated with venous thromboembolism in Thai population.
    Bhoopat L; Rojnuckarin P; Hiransuthikul N; Intragumtornchai T
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):758-63. PubMed ID: 20885294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low CD34(+) cells, high neutrophils and the metabolic syndrome are associated with an increased risk of venous thromboembolism.
    Rattazzi M; Villalta S; Galliazzo S; Del Pup L; Sponchiado A; Faggin E; Bertacco E; Buso R; Seganfreddo E; Pagliara V; Callegari E; Puato M; Caberlotto L; Scannapieco G; Fadini GP; Pauletto P
    Clin Sci (Lond); 2013 Aug; 125(4):211-8. PubMed ID: 23506051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
    Legnani C; Preda L; Palareti G; Lunghi B; Rossi E; Coccheri S
    Haematologica; 2002 Feb; 87(2):182-8. PubMed ID: 11836169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.